|
[1]Musso G, Gambino R, Cassader M.Non-alcoholic fatty liverdisease from pathogenesis to management:an update[J].Obes Rev, 2010, 11 (6) :430-445.
|
|
[2]Kamada Y, Takehara T, Hayashi N.Adipocytokines and liverdisease[J].J Gastroenterol, 2008, 43 (11) :811-822.
|
|
[3]Low S, Chin MC, Ma S, et al.Rationale for redefining obesityin Asians[J].Ann Acad Med Singapore, 2009, 38 (1) :66-69.
|
|
[4]中华医学会.非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志, 2006, 14 (3) :161-163.
|
|
[5]沙卫红, 李瑜元.2009年美国消化疾病会议周概况[J].中华消化杂志, 2009, 29 (8) :547-549.
|
|
[6]Fierbinteanu-Braticevici C, Dina I, Petrisor A, et al.Noninvasiveinvestigations for non alcoholic fatty liver disease and liverfibrosis[J].World J Gastroenterol, 2010, 16 (38) :4784-4791.
|
|
[7]Lewis JR, Mohanty SR.Nonalcoholic fatty liver disease:areview and update[J].Dig Dis Sci, 2010, 55 (3) :560-578.
|
|
[8]Balsano C, Alisi A, Nobili V.Liver fibrosis and therapeuticstrategies:the goal for improving metabolism[J].Curr DrugTargets, 2009, 10 (6) :505-512.
|
|
[9]Lonardo A, Carani C, Carulli N, et al.'Endocrine NAFLD'ahormonocentric perspective of nonalcoholic fatty liver diseasepathogenesis[J].J Hepatol, 2006, 44 (6) :1196-1207.
|
|
[10]Fukuhara A, Matsuda M, Nishizawa M, et al.Visfatin:a proteinsecreted by visceral fat that mimics the effects of insulin[J].Science, 2005, 307 (5708) :426-430.
|
|
[11]Targher G, Bertolini L, Rodella S, et al.Associations betweenplasma adiponectin concentrations and liver histologyin patients with nonalcoholic fatty liver disease[J].ClinEndocrinol (Oxf) , 2006, 64 (6) :679-683.
|